Home
Key Data
Bayer Stock
Management Report
Overview of Sales, Earnings and Financial Position
Economic Outlock
Sales and Earnings Forecast
Corporate Structure
Performance by Subgroup, Segment and Region
HealthCare
CropScience
MaterialScience
Business Development by Region
Calculation of EBIT(DA) Before Special Items
Core Earnings Per Share
Financial Position of the Bayer Group
Growth and Innovation
HealthCare
CropScience
MaterialScience
Employees
Opportunities and Risks
Events After the End of the Reporting Period
Financial Statements
Income Statements
Comprehensive Income
Financial Position
Statements of Cash Flows
Changes in Equity
Notes to the Condensed Consolidated Interim Financial Statements of the Bayer Group
Key Data by Segment
Key Data by Region
Explanatory Notes
Focus
News
Overview
Bayer sets ambitious targets for 2014
Better storability and longer shelf life
U.S. approval for Natazia to treat heavy menstrual bleeding (only available for specialized journalists)
Proven effectiveness in prevention and treatment (only available for specialized journalists)
Otto Bayer Award for sustainable chemistry
Further approval for EYLEA eye medicine
(only available for specialized journalists)
Dual protection against weeds and insects
Agreement to advance wheat breeding
Studies with cancer drug (only available for specialized journalists)
More energy generated than consumed
Protecting the health of bees
Expanding the soybean business
CO
2
project among the best ideas for the future
Investments in plants in Germany
Increased focus on interventional medicine
Service
Overview
Download Center
News of the first quarter 2012
Bayer Group
Bayer sets ambitious targets for 2014
» more
Bayer CropScience
Dual protection against weeds and insects
» more
News Overview
Focus
Innovation with a future
They can be hard and tough or soft and flexible. They improve people’s quality of life – and play a key role in climate protection: polyurethanes. Indeed, the modern world would be inconceivable without these plastics – which were invented in Leverkusen 75 years ago.
» more
Key Data
Bayer Group
The Bayer Group saw an encouraging start to 2012. Read more about sales, EBIT, EBITDA, net income, cash flow and number of employees.
» more
Bayer Stock
Investor Information
Bayer stock developed positively in the first quarter of 2012, albeit underperforming the DAX and
EURO STOXX 50 indices.
» more
Management Report
Overview of Sales, Earnings and Financial Position
Adjusted for currency and portfolio effects, sales moved ahead by 5.2% to the record level of €10.1 billion (reported: +6.8%; Q1 2011: €9.4 billion).
» more
Financial Statements
Bayer Group Consolidated Income Statements
Read more about net sales, EBIT and non-operating result.
» more
Print page
Search
Search
Download Center
Complete
Stockholder's Newsletter
(
PDF
9173 KB)
Add to Download Center
Your Selection:
Links
Annual Stockholders' Meeting 2012
Investor Conference Call
Financial Reports
Publications
Annual Reports
Sustainable Development Reports
Services
Order print version
Event Reminder
Press Newsletter
Quarterly Reports Newsletter
SMS Service
Bayer Links
Bayer Global
Bayer HealthCare
Bayer CropScience
Bayer MaterialScience
Bayer Business Services
Bayer Technology Services
Currenta
Special Interest
Investor Relations
Press
Jobs and Career
Foundations
Social Media
» Bayer Group
Deutsch
Sitemap
Search
RSS
Contact